H Rahimtoola1, H Buurma, C C Tijssen
1Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands. h.rahimtoola@pharm.uu.nl
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Most migraine prophylactic treatments are stopped or switched within a year. Younger patients and those using other medications were more likely to modify their migraine drug regimen.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: